Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand.

April 24, 2025. More for You ...

Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global ...

In this edition of Daily Dose, Dr. Lacy Anderson answers a viewer's question about what discounts are available for weight ...

Fact checked by Nick Blackmer Hospital trips tied to semaglutide—the active ingredient in Ozempic and Wegovy—are rare, but ...

In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...

Eli Lilly Takes on Novo Nordisk with Orforglipron, an Oral Drug for Diabetes and Obesity That Could Change the Market. FDA ...

Indian diabetic population on Human Mixtard concerned on changes in insulin therapy: Nandita Vijayasimha, Bengaluru Thursday, April 24, 2025, 08:00 Hrs [IST] India’s diabetic po ...

Your doctor will show you how to use your pen before your first dose ... You can learn more about the differences between Ozempic and Wegovy here. You should always follow your doctor’s ...

A DAD once nicknamed “Fat Pal” by his friends has dropped five stone in five months after using Mounjaro. Sean Burns, 32, from Glasgow, said he has “struggled with excess weight” his whole life ...

Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...